Get 20% Free Customization In This Report

Buy this report from - $3456

Hydroxytryptamine Receptor Market by Product Type (HTR6, HTR2B, and Others) and by Application (Attention Deficit Hyperactivity Disorder, Psychiatric Disorders, Alzheimers Disease, Chronic Obstructive Pulmonary Disease, and Memory Impairment) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Pharmaceuticals	LI_183320	Pages: NA	Jun 2018 \| 708 Views
Author's : NA	Tables: NA	Charts: NA	Formats*:

Hydroxytryptamine receptors are a group of G-protein coupled receptors and ligand gated ion channels, which are found in the peripheral and central nervous system. These receptors influence various biological and neurological processes such as aggression, anxiety, learning, mood, nausea, sleep, and cognition.

Due to the unique properties, hydroxytryptamine receptors are used in a variety of drugs such as antidepressants, antipsychotics, antimigraine agents, hallucinogens, and entactogens. This factor drives the growth of the market. However, prolonged use of 5-HT receptor drugs may cause mental disorders with complex etiologies, which impede the market.

The global hydroxytryptamine receptors market is segmented based on product type, applications, and geography. Based on product type, the market is classified into HTR6, HTR2B, and others. Further, based on application, it is divided into attention deficit hyperactivity disorder, psychiatric disorders, Alzheimers disease, chronic obstructive pulmonary disease (COPD), and memory impairment. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players such as Adamed, Avineuro Pharmaceutical, Axovant Sciences, Biotie Therapies, Celon Pharma, Galenea Corp, H. Lundbeck, Reviva Pharmaceuticals, Suven Life Sciences, and Teva Pharmaceutical Industries Ltd. are also provided in this report.

Key Benefits:

This report provides an extensive analysis of the current and emerging market trends and dynamics in the global hydroxytryptamine receptors market.
In-depth analysis is conducted by constructing market estimations for the key market segments between 2016 and 2023.
This study evaluating competitive landscape and value chain is taken into account to help understand the competitive environment across the geographies.
Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
This report provides the quantitative analysis of the current market and estimations through 2016-2023, which assists in identifying the prevailing market opportunities
Comprehensive analysis of all regions are provided that determines the prevailing opportunities in these geographies.

Hydroxytryptamine Receptor Market Key Segments:

By Product Type

HTR6
HTR2B
Others

By Application

Attention Deficit Hyperactivity Disorder
Psychiatric Disorders
Alzheimer's Disease
Chronic Obstructive Pulmonary Disease
Memory Impairment

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- U.K
- France
- Germany
- Spain
- Rest of Europe
Asia-Pacific
- China
- India
- Australia
- Japan
- Rest of Asia-Pacific
LAMEA
- Brazil
- Turkey
- Saudi Arabia
- South Africa
- Rest of LAMEA

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter: 4 HYDROXYTRYPTAMINE RECEPTOR MARKET, BY PRODUCT TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. HTR6

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. HTR2B

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. OTHERS

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

Chapter: 5 HYDROXYTRYPTAMINE RECEPTOR MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. ATTENTION DEFICIT HYPERACTIVITY DISORDER

5.2.1. Market size and forecast

5.3. PSYCHIATRIC DISORDERS

5.3.1. Market size and forecast

5.4. ALZHEIMER'S DISEASE

5.4.1. Market size and forecast

5.5. CHRONIC OBSTRUCTIVE PULMONARY DISEASE

5.5.1. Market size and forecast

5.6. MEMORY IMPAIRMENT

5.6.1. Market size and forecast

Chapter: 6 HYDROXYTRYPTAMINE RECEPTOR MARKET, BY REGION

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast

6.2.4. North America Hydroxytryptamine Receptor Market by Product Type
6.2.5. North America Hydroxytryptamine Receptor Market by Applications

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Spain market size and forecast
6.3.3.5. Rest of Europe market size and forecast

6.3.4. Europe Hydroxytryptamine Receptor Market by Product Type
6.3.5. Europe Hydroxytryptamine Receptor Market by Applications

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. Rest of Asia-Pacific market size and forecast

6.4.4. Asia-Pacific Hydroxytryptamine Receptor Market by Product Type
6.4.5. Asia-Pacific Hydroxytryptamine Receptor Market by Applications

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. Brazil market size and forecast
6.5.3.2. Turkey market size and forecast
6.5.3.3. Saudi Arabia market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast

6.5.4. LAMEA Hydroxytryptamine Receptor Market by Product Type
6.5.5. LAMEA Hydroxytryptamine Receptor Market by Applications

Chapter: 7 COMPANY PROFILES

7.1. ADAMED

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. AVINEURO PHARMACEUTICAL

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. AXOVANT SCIENCES

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. BIOTIE THERAPIES

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. CELON PHARMA

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.6. GALENEA CORP

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments

7.7. H. LUNDBECK

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. REVIVA PHARMACEUTICALS

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments

7.9. SUVEN LIFE SCIENCES

7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments

7.10. H TEVA PHARMACEUTICAL INDUSTRIES LTD.

7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.